Inactive Instrument

News Diamyd Medical AB Swiss Exchange

Equities

SE0005162880

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

Apr. 18	Diamyd Medical Raises SEK57 Million in Rights Issue	MT
Apr. 12	Recruitment Milestone Reaches in Diamyd® Phase 3 Trial	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Diamyd Medical Raises SEK57 Million in Rights Issue	Apr. 18	MT
Diamyd Medical announces final outcome in the company's rights issue	Apr. 18	AQ
Diamyd Medical announces preliminary outcome in the company's rights issue	Apr. 16	AQ
Recruitment milestone reached in Diamyd® Phase 3 trial	Apr. 12	AQ
Recruitment Milestone Reaches in Diamyd® Phase 3 Trial	Apr. 12	CI
Diamyd Medical led ASSET innovation partnership organizes a workshop on the future treatment of Type 1 Diabetes	Apr. 11	AQ
Diamyd Medical's main Shareholders announce their subscription commitments in the ongoing rights issue	Apr. 05	AQ
Diamyd Medical publishes prospectus with regards to the rights issue	Mar. 28	AQ
Quarterly Report II 23/24	Mar. 27	AQ
Diamyd Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Mar. 27	CI
Diamyd Medical to Raise SEK114 Million Via Share Offering	Mar. 19	MT
The Board of Directors in Diamyd Medical have resolved on a rights issue of approximately SEK 114 million	Mar. 18	AQ
Diamyd Medical to present new genetic data at the ASIT summit in Boston, MA	Feb. 29	AQ
Diamyd Medical to Present New Genetic Data at the ASIT Summit in Boston, MA	Feb. 29	CI
Diamyd Medical Secures US FDA Fast Track Designation for Type 1 Diabetes Treatment	Feb. 15	MT
Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®	Feb. 15	AQ
Publication in Diabetologia highlights AI's potential for Type 1 Diabetes screening	Feb. 14	AQ
In-depth analysis of Diamyd® Phase II trial further supports value of preserved insulin secretion	Jan. 24	AQ
In-Depth Analysis of Diamyd Medical AB's Phase II Trial Further Supports Value of Presented Insulin Production	Jan. 24	CI
Quarterly Report I 23/24	Jan. 24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Diamyd Medical AB Swiss Exchange

Equities

SE0005162880

Summary

Filters